ANGIODYNAMICS INC — Form 8-K
Filed October 8, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 62/100
What the filing says
AngioDynamics appointed Eric Honroth as President and CEO effective November 2, 2026, with a $735,000 annual base salary, 95% target bonus, and sign-on inducements totaling $800,000 (cash bonus $350,000 + RSU equity buyout $450,000) plus a 350% base salary inducement award. Outgoing CEO Jim Clemmer retires and transitions to a consulting role at $30,000/month for 12 months. The company has no outstanding debt and operates with strong balance sheet momentum.
Why this rating
Leadership transition is material (60-84 range) but company maintains stability: new CEO brings 20+ years med-tech experience; $800K sign-on is 0.18% of $436M market cap (modest); outgoing CEO structured as advisor; no business operations disruption evident. Neutral because succession appears orderly, both parties supportive, and no strategic change indicated.
See more from October 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.